Development and prioritisation of policy recommendations for medication safety improvement for intensive care units : a European Association of Hospital Pharmacists Special Interest Group Delphi Study
© European Association of Hospital Pharmacists 2024. No commercial re-use. See rights and permissions. Published by BMJ..
OBJECTIVES: Medication errors (MEs) are a leading cause of morbidity and mortality in the healthcare system. Patients admitted to intensive care units (ICUs) are potentially more susceptible to MEs due to severity of illness, the complexity of treatments they receive and the challenging nature of the ICU setting. The European Association of Hospital Pharmacists established a Special Interest Group (SIG) to undertake a programme of work to develop and prioritise recommendations to support medication safety improvement in ICUs across Europe.
METHODS: Initial policy recommendations for medication safety within the ICU environment were developed following reviews of the literature and engagement with relevant stakeholders. A Delphi panel of 21 members of the SIG, that comprised healthcare professionals (HCPs) with expertise in ICU and/or medication safety, was convened in 2022. We conducted two rounds using a modified Delphi technique whereby participants anonymously ranked on a 9-point Likert Scale the policy recommendations according to their priority for implementation.
RESULTS: In total, 32 policy recommendations were developed. In Delphi Round 1, 19 HCPs participated; consensus was achieved on most recommendations and partial consensus on six. In Delphi Round 2, 18 HCPs participated. After two Delphi rounds, consensus was achieved on all 32 recommendations. All recommendations were considered 'high priority' except one that was considered 'medium priority'.
CONCLUSIONS: Through this study it was possible to develop and prioritise evidence-based policy recommendations to enhance medication safety, which may contribute to reducing MEs in ICUs across Europe. All recommendations were considered 'high priority' for implementation except one, indicating the perceived value of these recommendations in improving medication safety through preventing MEs in ICUs.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
European journal of hospital pharmacy : science and practice - (2024) vom: 17. Apr. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Howlett, Moninne [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
CRITICAL CARE |
|---|
| Anmerkungen: |
Date Revised 17.04.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.1136/ejhpharm-2023-004065 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM37093928X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM37093928X | ||
| 003 | DE-627 | ||
| 005 | 20240418233028.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240412s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/ejhpharm-2023-004065 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1379.xml |
| 035 | |a (DE-627)NLM37093928X | ||
| 035 | |a (NLM)38604615 | ||
| 035 | |a (PII)ejhpharm-2023-004065 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Howlett, Moninne |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Development and prioritisation of policy recommendations for medication safety improvement for intensive care units |b a European Association of Hospital Pharmacists Special Interest Group Delphi Study |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 17.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a © European Association of Hospital Pharmacists 2024. No commercial re-use. See rights and permissions. Published by BMJ. | ||
| 520 | |a OBJECTIVES: Medication errors (MEs) are a leading cause of morbidity and mortality in the healthcare system. Patients admitted to intensive care units (ICUs) are potentially more susceptible to MEs due to severity of illness, the complexity of treatments they receive and the challenging nature of the ICU setting. The European Association of Hospital Pharmacists established a Special Interest Group (SIG) to undertake a programme of work to develop and prioritise recommendations to support medication safety improvement in ICUs across Europe | ||
| 520 | |a METHODS: Initial policy recommendations for medication safety within the ICU environment were developed following reviews of the literature and engagement with relevant stakeholders. A Delphi panel of 21 members of the SIG, that comprised healthcare professionals (HCPs) with expertise in ICU and/or medication safety, was convened in 2022. We conducted two rounds using a modified Delphi technique whereby participants anonymously ranked on a 9-point Likert Scale the policy recommendations according to their priority for implementation | ||
| 520 | |a RESULTS: In total, 32 policy recommendations were developed. In Delphi Round 1, 19 HCPs participated; consensus was achieved on most recommendations and partial consensus on six. In Delphi Round 2, 18 HCPs participated. After two Delphi rounds, consensus was achieved on all 32 recommendations. All recommendations were considered 'high priority' except one that was considered 'medium priority' | ||
| 520 | |a CONCLUSIONS: Through this study it was possible to develop and prioritise evidence-based policy recommendations to enhance medication safety, which may contribute to reducing MEs in ICUs across Europe. All recommendations were considered 'high priority' for implementation except one, indicating the perceived value of these recommendations in improving medication safety through preventing MEs in ICUs | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a CRITICAL CARE | |
| 650 | 4 | |a MEDICAL ERRORS | |
| 650 | 4 | |a MEDICATION SYSTEMS, HOSPITAL | |
| 650 | 4 | |a PHARMACY SERVICE, HOSPITAL | |
| 650 | 4 | |a Practice Guidelines as Topic | |
| 650 | 4 | |a Safety | |
| 700 | 1 | |a McCarthy, Suzanne |e verfasserin |4 aut | |
| 700 | 1 | |a Silvari, Virginia |e verfasserin |4 aut | |
| 700 | 1 | |a Franklin, Bryony Dean |e verfasserin |4 aut | |
| 700 | 1 | |a Laaksonen, Raisa |e verfasserin |4 aut | |
| 700 | 0 | |a EAHP Special Interest Group for the investigation of medication errors in intensive care units |e verfasserin |4 aut | |
| 700 | 1 | |a Amigoni, Angela |e investigator |4 oth | |
| 700 | 1 | |a Aquerreta, Irene |e investigator |4 oth | |
| 700 | 1 | |a Bürmen, Božena |e investigator |4 oth | |
| 700 | 1 | |a Burch, Andrea |e investigator |4 oth | |
| 700 | 1 | |a Chapuis, Claire |e investigator |4 oth | |
| 700 | 1 | |a Cooper, Suzanne |e investigator |4 oth | |
| 700 | 1 | |a Dade, John |e investigator |4 oth | |
| 700 | 1 | |a Franklin, Bryony Dean |e investigator |4 oth | |
| 700 | 1 | |a De Lange, Dylan W |e investigator |4 oth | |
| 700 | 1 | |a Howlett, Moninne |e investigator |4 oth | |
| 700 | 1 | |a Kurttila, Minna |e investigator |4 oth | |
| 700 | 1 | |a Laaksonen, Raisa |e investigator |4 oth | |
| 700 | 1 | |a Lamesta, Chiara |e investigator |4 oth | |
| 700 | 1 | |a Lass, Jana |e investigator |4 oth | |
| 700 | 1 | |a Martin, Maria Cruz |e investigator |4 oth | |
| 700 | 1 | |a McCarthy, Suzanne |e investigator |4 oth | |
| 700 | 1 | |a Silvari, Virginia |e investigator |4 oth | |
| 700 | 1 | |a Sviestina, Inese |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of hospital pharmacy : science and practice |d 2012 |g (2024) vom: 17. Apr. |w (DE-627)NLM225772213 |x 2047-9956 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:17 |g month:04 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/ejhpharm-2023-004065 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 17 |c 04 | ||